New Clinical Trial Will Use Artificial Antibodies to Treat Covid19 Lung Inflammation
Gimsilumab, an artificially synthesized antibody, could significantly reduce Covid19-related lung injuries.
Devrupa Rakshit is an Associate Editor at The Swaddle. She is a lawyer by education, a poet by accident, a painter by shaukh, and autistic by birth. You can find her on Instagram @devruparakshit.